bioRxiv Science⌕ Search

bioRxiv · 10.1101/155713

Modelling of the cardiopulmonary responses to maximal aerobic exercise in patients with cystic fibrosis

Abstract

Cystic fibrosis (CF) is a debilitating chronic condition, which requires complex and expensive disease management. Exercise has now been recognised as a critical factor in improving health and quality of life in patients with CF. Hence, cardiopulmonary exercise testing (CPET) is used to determine aerobic fitness of young patients as part of the clinical management of CF. However, at present there is a lack of conclusive evidence for one limiting system of aerobic fitness for CF patients at an individual patient level.\n\nHere, we perform detailed data analysis that allows us to identify important systems-level factors that affect aerobic fitness. We use patients data and principal component analysis to confirm the dependence of CPET performance on variables associated with ventilation and metabolic rates of oxygen consumption. We find that the time at which participants cross the anaerobic threshold (AT) is well correlated with their overall performance. Furthermore, we propose a predictive modelling framework that captures the relationship between ventilatory dynamics, lung capacity and function and performance in CPET within a group of children and adolescents with CF. Specifically, we show that using Gaussian processes (GP) we can predict AT at the individual patient level with reasonable accuracy given the small sample size of the available group of patients. We conclude by presenting future perspectives for improving and extending the proposed framework.\n\nOur modelling and analysis have the potential to pave the way to designing personalised exercise programmes that are tailored to specific individual needs relative to patients treatment therapies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Williams, C. A., Wedgwood, K. C. A., Mohammadi, H., Tomlinson, O. W., Tsaneva-Atanasova, K.. 2017-06-26. Modelling of the cardiopulmonary responses to maximal aerobic exercise in patients with cystic fibrosis. https://doi.org/10.1101/155713

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Age-related biological dysregulation quantified using metabolomics is composed of distinct subsystems with synergistic associations to health outcomes: An analysis of the Canadian Longitudinal Study on Aging

Resilience is a fundamental component of healthy aging, whereby an organism can efficiently respond to external stressors and return to a resting biological and physiological state, known as homeostasis. This capacity declines with age in a heterogenous manner and is aggravated by biological dysregulation, a detrimental state broadly associated with health risk factors and poor outcomes. However, the underlying structure of dysregulation remains unclear, particularly in the context of older adult health trajectories. Here, we take a novel systems-based approach to the quantification of dysregulation using metabolomic data from n=9,992 older adults enrolled in the Canadian Longitudinal Study on Aging. We show that dysregulation across different biological systems is heritable, and exhibit distinct associations with health risk factors, indicators and outcomes, and DNA methylation patterns. Importantly, the effect of systems-specific dysregulation is cumulative, resulting in a significantly higher risk of disease incidence and death in older adults. Our findings broaden our understanding of biological dysregulation as a health state and demonstrate the value of system-specific dysregulation for effective strategies in personalized medicine and risk stratification.

physiology↗

An LRH-1 agonist reverses hepatic metabolic dysfunction in obesity

Liver receptor homolog-1 (LRH-1; NR5A2) is a nuclear receptor that controls metabolic gene programs important for liver health. Here, we address two challenges with dissecting ligand-driven LRH-1 metabolism in vivo. First, we generate ME610, a potent LRH-1 agonist with favorable pharmacokinetic properties. Second, we engineer Nr5a2humLBD mice, edited to recapitulate the ligand response of the human receptor. ME610 dose-dependently induces LRH-1 target genes and reduces triglycerides in livers of Nr5a2humLBD mice. In a mouse model of diet-induced obesity (DIO), ME610 dramatically improves insulin sensitivity and reduces liver fat. Multi-omics integration of transcriptomics, lipidomics, and metabolomics data demonstrates a coordinated reversal of DIO-induced hepatic metabolic stress via changes in lipid, amino acid, and energy metabolism, with peroxisomal lipid metabolism emerging as a central process correlated to efficacy. These studies uncover new pathways through which LRH-1 regulates metabolism and demonstrate the therapeutic potential of synthetic LRH-1 agonists in obesity-associated metabolic diseases.

physiology↗

SCN- induces prestin contraction through reduced intermonomer angles and a modified transporter like movement of each monomer.

Prestin is the membrane based molecular motor responsible for outer hair cell electromotility that expands and contracts in response to transmembrane voltage. How voltage brings these about is unknown but cryoEM structures in the presence of ligands has led to the extrapolation of structures with the transporter cycle and its expansion contraction coupling. We find prestin to adopt novel increasingly contracted states that are brought about by a reduced intermonomer angles in the obligate dimers and a transmembrane contraction of each monomer at its cytoplasmic half in the presence of SCN-. These changes are associated with a loss in the intermonomer beta sheet at its N terminus. There is a hyperpolarizing shift in Vh along with increased affinity for SCN-. SCN- binding at the internal binding site likely cause the structural changes since they are reversed by SCN- displacement by salicylate.

physiology↗